Cellbion CEO “We’ll Prove Orphan Drug Success...Next Month Is the Turning Point” 유진희 2025.11.17 오전 10:30 Curacle jumps on Boryung tie-up; NextBiomedical climbs[K-bio Pulse] 석지헌 2025.09.12 오전 07:54 Limit-Up L&C Bio: “No CAPA Issues”; Lituo Shortage Easing Soon[K-Bio Pulse] 나은경 2025.09.08 오전 09:30 From Corestem to Yuhan: Cellbion Eyes Fast-Track Path for Lu-177-DGUL 유진희 2025.08.27 오전 08:27 Cellbion's Radiopharmaceutical Gains Global Pharma Attention, Expanding Collaborations Expec... 유진희 2025.03.04 오후 01:44 Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties 유진희 2025.09.05 오전 08:30 CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse] 김진수 2025.03.27 오전 08:29 SK바이오팜, 7900억 규모 방사성의약품 후보물질 첫 도입...RPT 사업 본격화 김승권 2024.07.17 오전 10:13 Sellbion CEO Kwon Kim: “Maximizing the Power of 177Lu-DGUL Immuno-Oncology Combo” 유진희 2025.07.21 오전 09:30 Selbion Up 2 Days, Eyes Lekraza Upside[[K-Bio Pulse] 석지헌 2025.07.25 오전 08:30 더 보기 로딩중..
radiopharmaceutical
radiopharmaceutical
![Curacle jumps on Boryung tie-up; NextBiomedical climbs[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/09/PS25091200180b.jpg)
![Limit-Up L&C Bio: “No CAPA Issues”; Lituo Shortage Easing Soon[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/09/PS25090800358b.jpg)
![CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032700436b.jpg)
![Selbion Up 2 Days, Eyes Lekraza Upside[[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/07/PS25072500367b.jpg)